GGT1 and renal cell carcinoma: Furthermore, in RCC patients, elevated serum GGT levels are linked to a worse prognosis and survival15–17, suggesting that modulating the GSH-based antioxidant system, especially thru GGT1 activity, ought to be a promising therapeutic method for overcoming chemoresistance and slowing the development of KIRC18.